A comparison between simulated and experimental basis sets for assessing short-TE in vivo 1H MRS data at 1.5 T

NMR in Biomedicine

Volumn 23, Issue 10, 2010, Pages 1117-1126

  Wilson, Martin ^a,b   Davies, Nigel P ^a,b,c   Sun, Yu ^a,b   Natarajan, Kal ^a,c   Arvanitis, Theodoros N ^a,b   Kauppinen, Risto A ^d   Peet, Andrew C ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Brain; LCModel; MRS; Paediatric; Tumour

Indexed keywords

BASIS FUNCTIONS; BASIS SETS; BRAIN TUMOURS; CRAMER-RAO LOWER BOUND; DATA QUALITY; FITTING ERROR; FREQUENCY-SHIFTING; IN-VIVO; LCMODEL; METABOLITE CONCENTRATIONS; METABOLITE SPECTRA; MONTE CARLO ANALYSIS; MONTE CARLO SIMULATION; MRS; PAEDIATRIC; QUALITY DATA; SMALL VARIATIONS; SYSTEMATIC STUDY; TUMOUR;

BIOMOLECULES; CRAMER-RAO BOUNDS; ERRORS; METABOLISM; PEDIATRICS; TUMORS;

METABOLITES;

ALGORITHM; ARTICLE; BRAIN TUMOR; COMPARATIVE STUDY; COMPUTER PROGRAM; IMAGE QUALITY; IN VIVO STUDY; MONTE CARLO METHOD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIMULATION;

CHILD; COMPUTER SIMULATION; CREATINE; HUMANS; MONTE CARLO METHOD; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTONS;

EID: 78650288509     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1538     Document Type: Article

References (35)

1. Panigrahy A, Nelson MD Jr, Finlay JL, Sposto R, Krieger MD, Gilles FH, Bluml S. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol. 2008; 10(1): 32-44.
2. Cordery RJ, MacManus D, Godbolt A, Rossor MN, Waldman AD. Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol. 2006; 16(8): 1692-1698.
3. Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, Stangl H, Raffer E, Niederhofer H, Ladurner G. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2005; 17(3): 357-363.
4. Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage. 2004; 23(4): 1336-1347.
5. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(8): 1313-1322.
6. Peet AC, Davies NP, Ridley L, Brundler MA, Kombogiorgas D, Lateef S, Natarajan K, Sgouros S, MacPherson L, Grundy RG. Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma. Eur J Cancer. 2007; 43: 1037-1044.
7. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med. 1996; 2(3): 323-325.
8. Opstad KS, Ladroue C, Bell BA, Griffiths JR, Howe FA. Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. NMR Biomed. 2007; 20(8): 763-770.
9. Davies NP, Wilson M, Harris LM, Natarajan K, Lateef S, MacPherson L, Sgouros S, Grundy RG, Arvanitis TN, Peet AC. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed. 2008; 21(8): 908-918.
10. Dowling C, Bollen A, Noworolski S, McDermott M, Barbaro N, Day M, Henry R, Chang S, Dillon W, Nelson S, Vigneron D. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol. 2001; 22(4): 604-612.
11. Ng WH, Lim T. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy. J Clin Neurosci. 2008; 15(5): 502-506.
12. Pulkkinen J, Hakkinen AM, Lundbom N, Paetau A, Kauppinen RA, Hiltunen Y. Independent component analysis to proton spectroscopic imaging data of human brain tumours. Eur J Radiol. 2005; 56(2): 160-164.
13. Graves E, Nelson S, Vigneron D, Verhey L, McDermott M, Larson D, Chang S, Prados M, Dillon W. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. Am J Neuroradiol. 2001; 22(4): 613-624.
14. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn J, Alger J, DiChiro G. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg. 1997; 87(4): 516-524.
15. van der Veen JW, de Beer R, Luyten PR, van Ormondt D. Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med. 1988; 6(1): 92-98.
16. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997; 129(1): 35-43.
17. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993; 30(6): 672-679.
18. Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C. Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med. 2004; 51(5): 904-912.
19. Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D. Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed. 2005; 18(1): 1-13.
20. Poullet JB, Sima DM, Simonetti AW, De Neuter B, Vanhamme L, Lemmerling P, Van Huffel S. An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES. NMR Biomed. 2007; 20(5): 493-504.
21. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3): 129-153.
22. Smith S, Levante T, Meier B, Ernst R. Computer simulations in magnetic resonance: an object oriented programming approach. J Magn Reson. 1994; 106(1): 75-105.
23. Blanton WB. Blochlib: a fast NMR C++ tool kit. J Magn Reson. 2003; 162(2): 269-283.
24. Graveron-Demilly D, Diop A, Briguet A, Fenet B. Product-operator algebra for strongly coupled spin systems. J Magn Reson. 1993; 101(3): 233-239.
25. Soher BJ, Young K, Bernstein A, Aygula Z, Maudsley AA. Gava: spectral simulation for in vivo MRS applications. J Magn Reson. 2007; 185(2): 291-299.
26. Cudalbu C, Cavassila S, Rabeson H, van Ormondt D, Graveron-Demilly D. Influence of measured and simulated basis sets on metabolite concentration estimates. NMR Biomed. 2008; 21(6): 627-636.
27. Barkovitch AJ. Pediatric Neuroimaging. Lippincott Williams & Wilkins: Philadelphia, 2005.
28. Wright AJ, Arus C, Wijnen JP, Moreno-Torres A, Griffiths JR, Celda B, Howe FA. Automated quality control protocol for MR spectra of brain tumors. Magn Reson Med. 2008; 59(6): 1274-1281.
29. MATLAB programming language. Mathworks Inc.
30. Levitt MH. Spin Dynamics: Basics of Nuclear Magnetic Resonance. Wiley: Chichester, 2001.
31. de Graaf R. In vivo NMR Spectroscopy - Principles and Techniques. Wiley: Chichester, 2007.
32. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476): 307-310.
33. Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D. Cramer-Rao bounds: an evaluation tool for quantitation. NMR Biomed. 2001; 14(4): 278-283.
34. Xin L, Gambarota G, Mlynarik V, Gruetter R. Proton T2 relaxation time of J-coupled cerebral metabolites in rat brain at 9.4 T. NMR Biomed. 2008; 21(4): 396-401.
35. Reynolds G, Wilson M, Peet A, Arvanitis TN. An algorithm for the automated quantitation of metabolites in in-vitro NMR signals. Magn Reson Med. 2006; 56(6): 1211-1219.